Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jaffe

Showing results (551-560 of 579) with videos related to

Pageof 58
Sort By:
The New England Journal of Medicine|September 8, 2016
Adalimumab in Patients with Active Noninfectious UveitisGlenn J Jaffe, Andrew D Dick, Antoine P Brézin, et al.
Ocular Immunology and Inflammation|July 18, 2018
Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II TrialsHiroshi Goto, Masahiro Zako, Kenichi Namba, et al.
Ophthalmology Science|June 9, 2023
Reticular Pseudodrusen: Interreader Agreement of Evaluation on OCT Imaging in Age-Related Macular DegenerationZhichao Wu, Steffen Schmitz-Valckenberg, Barbara A Blodi, et al.
Ophthalmology|December 29, 2023
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE TrialsTien Y Wong, Zdenka Haskova, Kemal Asik, et al.
Lancet (London, England)|September 11, 2023
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trialArshad M Khanani, Sunil S Patel, Giovanni Staurenghi, et al.
Ophthalmology Science|September 2, 2025
OCT-Defined Atrophic Age-Related Macular Degeneration Changes Associated with Deep Visual Sensitivity Losses: A Multicenter StudyZhichao Wu, Barbara A Blodi, Frank G Holz, et al.
Ophthalmology|September 22, 2016
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID StudiesJeffrey S Heier, Jean-François Korobelnik, David M Brown, et al.
American Journal of Ophthalmology|March 8, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity" [Am J Ophthalmol 2020;219:87-100]Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
American Journal of Ophthalmology|August 3, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity." Am J Ophthalmol. 2020; 219:87-100Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
American Journal of Ophthalmology|May 5, 2025
Natural History of Microperimetry and Optical Coherence Tomography in USH2A-Retinopathy: A Structure-Function Association StudyAjoy Vincent, Wendi Liang, Maureen G Maguire, et al.
Pageof 58

Showing results (551-560 of 579) with videos related to

Sort By:
Pageof 58
The New England Journal of Medicine|September 8, 2016
Adalimumab in Patients with Active Noninfectious UveitisGlenn J Jaffe, Andrew D Dick, Antoine P Brézin, et al.
Ocular Immunology and Inflammation|July 18, 2018
Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II TrialsHiroshi Goto, Masahiro Zako, Kenichi Namba, et al.
Ophthalmology Science|June 9, 2023
Reticular Pseudodrusen: Interreader Agreement of Evaluation on OCT Imaging in Age-Related Macular DegenerationZhichao Wu, Steffen Schmitz-Valckenberg, Barbara A Blodi, et al.
Ophthalmology|December 29, 2023
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE TrialsTien Y Wong, Zdenka Haskova, Kemal Asik, et al.
Lancet (London, England)|September 11, 2023
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trialArshad M Khanani, Sunil S Patel, Giovanni Staurenghi, et al.
Ophthalmology Science|September 2, 2025
OCT-Defined Atrophic Age-Related Macular Degeneration Changes Associated with Deep Visual Sensitivity Losses: A Multicenter StudyZhichao Wu, Barbara A Blodi, Frank G Holz, et al.
Ophthalmology|September 22, 2016
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID StudiesJeffrey S Heier, Jean-François Korobelnik, David M Brown, et al.
American Journal of Ophthalmology|March 8, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity" [Am J Ophthalmol 2020;219:87-100]Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
American Journal of Ophthalmology|August 3, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity." Am J Ophthalmol. 2020; 219:87-100Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
American Journal of Ophthalmology|May 5, 2025
Natural History of Microperimetry and Optical Coherence Tomography in USH2A-Retinopathy: A Structure-Function Association StudyAjoy Vincent, Wendi Liang, Maureen G Maguire, et al.
Pageof 58